Article
17 Dec 2025
CMS Obtains Meaningful Discounts For IPAY 2027 Selected Drugs
AUTHORS CONTENT
Article
20 Oct 2025
AstraZeneca Announces New Most-Favored-Nation Pricing Initiatives
Article
25 Aug 2025
Executive Order Directs HHS To Invest In Strategic Reserve Of Active Pharmaceutical Ingredients
Article
15 Aug 2025
FTC And DOJ Host Final Listening Session On Drug Prices
Article
08 Jul 2025
Cost Sharing Trends Show Broad Shifts in the Part D Market
Article
03 Jul 2025
Emerging Trends In Part D Formulary Design Following Implementation Of The IRA
Article
23 Jun 2025
PBMs Sue Arkansas Over Pharmacy Ownership Prohibition
Article
26 May 2025
CMS Releases Draft Guidance For IPAY 2028 Of Medicare Drug Price Negotiation Program
Article
29 Apr 2025
President Trump Signs Executive Order Proposing 13 Policy Directives On Drug Pricing
Article
29 Jan 2025
Policy Approaches To Improving Coverage Of Dyslexia Screening, Testing And Treatment
Article
28 Jan 2025
Five Key Policies To Improve Coverage Of Dyslexia Screening, Testing And Treatment
Article
28 Jan 2025
CMS Announces Additional Drugs Selected For 2027 IRA Medicare Drug Price Negotiation
Article
23 Jan 2025
Evaluation Of Drug Pricing Policies Under A Potential Reconciliation Package
Article
27 Dec 2024
CMS Clarifies MA Coverage Requirements For ALS Treatment
Article
17 Dec 2024
CMS Proposes Coverage Of Anti-Obesity Medications, Other MA And Part D Changes For 2026
Article
22 Nov 2024
J&J Sues HRSA Over Agency's Challenge Of Its Rebate Model